Chronic Pulmonary Aspergillosis with Tracheobronchial Involvement
Downloads
Introduction: Aspergillosis is a fungal infection commonly found in human lungs and takes several forms. Chronic pulmonary aspergillosis (CPA) commonly affects individuals with underlying disease, most usually lung tuberculosis (TB). Aspergillosis can cause the formation of a fungus ball in the lung cavity and can also manifest in the tracheobronchial area, although this is rarely seen in immunocompetent patients.
Case: A 23-year-old woman came with persistent cough, hemoptysis, and shortness of breath for 4 months. The patient also had a significant weight loss and a history of lung TB 3 years ago. She had completed her lung TB medication. Physical examination showed increased respiratory rate and rhonchi on the left lung. GeneXpert showed no Mycobacterium tuberculosis (MTB) detected. The chest X-ray showed a cavity on the left superior lobe of the lung. Bronchoscopy showed multiple plaques along the trachea, carina, and left main bronchus. A chest computed tomography (CT) scan with contrast enhancement was performed, and a fungus ball was found inside the cavity in the left upper lobe of the lung. The patient was given intravenous fluconazole as therapy and continued with oral fluconazole when discharged. A second bronchoscopy was performed, and improvement was shown.
Conclusion: Early detection and treatment should be applied to CPA patients since some studies showed poor prognosis and low five-year survival rates.
Grippi MA, Elias JA, Fishman J, et al. Fishman’s Pulmonary Diseases and Disorders. Epub ahead of print 2015. https://worldcat.org/title/904408460.
Lamoth F, Calandra T. Pulmonary Aspergillosis: Diagnosis and Treatment. Eur Respir Rev 2022; 31: 220114. [PubMed]
Russo A, Tiseo G, Falcone M, et al. Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment. Infect Dis Ther 2020; 9: 511–524. [PubMed]
Qiu C, Lu PX, Wu SP. Pulmonary Aspergillosis Diagnosis and Cases: Diagnosis and Cases. Springer, 2019. Epub ahead of print 1 January 2019. [Springer]
Gu X, Hua YH, Zhang YD, et al. The Pathogenesis of Aspergillus fumigatus, Host Defense Mechanisms, and the Development of AFMP4 Antigen as a Vaccine. Polish J Microbiol 2021; 70: 3–11. [PubMed]
Zarif A, Thomas A, Vayro A. Chronic Pulmonary Aspergillosis: A Brief Review. Yale J Biol Med 2021; 94: 673–679. [PubMed]
Iqbal N, Irfan M, Mushtaq A, et al. Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA): An Experience from a Tertiary Care Hospital in Karachi, Pakistan. J Fungi (Basel, Switzerland); 6. Epub ahead of print March 2020. [PubMed]
Samanta P, Clancy CJ, Nguyen MH. Fungal Infections in Lung Transplantation. J Thorac Dis 2021; 13: 6695–6707. [PubMed]
Bongomin F, Asio LG, Baluku JB, et al. Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There is no Mycologist. J Fungi (Basel, Switzerland); 6. Epub ahead of print June 2020. [PubMed]
Lee SY, Nguyen P, Chapman S. Invasive Tracheal Aspergillosis after Chemoradiotherapy Treatment. Respirology Case Reports 2019; 7: e00473. [PubMed]
Cho JS, Kim JJ, Jeong SY, et al. Pseudomembranous Aspergillus Tracheobronchitis: Case Report of a Rare Manifestation of Airway Invasive Aspergillosis. Taehan Yongsang Uihakhoe chi 2022; 83: 737–743. [PubMed]
Wilopo BAP, Richardson MD, Denning DW. Diagnostic Aspects of Chronic Pulmonary Aspergillosis: Present and New Directions. Curr Fungal Infect Rep 2019; 13: 292–300. [Springer]
Osborne W, Fernandes M, Brooks S, et al. Pulsed Echinocandin Therapy in Azole Intolerant or Multiresistant Chronic Pulmonary Aspergillosis: A Retrospective Review at a UK Tertiary Centre. Clin Respir J 2020; 14: 571–577. [PubMed]
Aruanno M, Glampedakis E, Lamoth F. Echinocandins for the Treatment of Invasive Aspergillosis: From Laboratory to Bedside. Antimicrob Agents Chemother; 63. Epub ahead of print August 2019. [PubMed]
Lang M, Lang AL, Chauhan N, et al. Non-Surgical Treatment Options for Pulmonary Aspergilloma. Respir Med 2020; 164: 105903. [PubMed]
Jiang C, Dai J, Bao Y, et al. Surgical Treatment of Pulmonary Aspergilloma: A 13-year Experience from a Single Clinical Center. Ann Thorac Surg 2022; 114: 311–318. [PubMed]
Pihlajamaa K, Anttila VJ, Räsänen JV, et al. The Fate of Aspergilloma Patients after Surgical Treatment-Experience from 22 Cases. J Thorac Dis 2019; 11: 4298–4307. [PubMed]
Garner M, Brunswicker A. Surgical Management of Pulmonary Aspergilloma. Shanghai Chest; 7. Epub ahead of print 1 January 2021. [Journal]
Shen C, Qiao G, Wang C, et al. Outcomes of Surgery for Different Types of Chronic Pulmonary Aspergillosis: Results from a Single-Center, Retrospective Cohort Study. BMC Pulm Med 2022; 22: 40. [PubMed]
Courtwright AM, Longworth S, Chojnowski D, et al. Treatment of a Pulmonary Aspergilloma in a Lung Transplant Recipient Using Catheter-Directed Intracavitary Instillation of Liposomal Amphotericin B. Transplant Direct 2022; 8: e1270. [PubMed]
Ando T, Kawashima M, Masuda K, et al. Exacerbation of Chronic Pulmonary Aspergillosis was Associated with a High Rebleeding Rate after Bronchial Artery Embolization. Respir Investig 2019; 57: 260–267. [PubMed]
Kimura Y, Sasaki Y, Suzuki J, et al. Prognostic Factors of Chronic Pulmonary Aspergillosis: A Retrospective Cohort of 264 Patients from Japan. PLoS One 2021; 16: e0249455. [PubMed]
Maitre T, Cottenet J, Godet C, et al. Chronic Pulmonary Aspergillosis: Prevalence, Favouring Pulmonary Diseases and Prognosis. Eur Respir J; 58. Epub ahead of print August 2021. [PubMed]
Copyright (c) 2024 Yosua Kevin Hermawan, Anak Agung Ngurah Satya Pranata, Wayan Wahyu Semara Putra, I Wayan Sunaka, Novitasari Novitasari, Cokorda Rio Angelina
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.